EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeit

Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients

Sahib Singh, Aakash Garg, Udaya S Tantry, Kevin Bliden, Paul A Gurbel, Martha Gulati

Current Problems in Cardiology · 2024-03 · 49 (3) · 102403

DOI: 10.1016/j.cpcardiol.2024.102403 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Current Problems in Cardiology, 2024-03. Verfasst von Sahib Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Myocardial Infarction, Stroke. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Randomized controlled trials (RCTs) have shown variable cardiovascular (CV) outcomes in overweight or obese patients without diabetes mellitus (DM) who are treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) vs. placebo. We conducted a meta-analysis of the available studies. METHODS: Online databases were searched for RCTs comparing GLP-1 RA to placebo in overweight or obese non-diabetic patients. The clinical endpoints of interest were major adverse CV events (MACE), CV death, all cause death, myocardial infarction (MI), stroke, revascularization, total adverse events and their subtypes. Pooled odds ratios (OR) and 95 % confidence intervals (CI) were calculated using a random-effects model. RESULTS: A total of 10 RCTs with 29,325 patients (n = 16,900 GLP-1 RA, n = 12,425 placebo) were included. The mean age was 48 years and 34 % of patients were men. As compared with placebo, the GLP-1 RA group was associated with significant reduction of MACE (OR 0.79, 95 % CI 0.71-0.89, p < 0.0001), all cause death (OR 0.80, 95 % CI 0.70-0.92, p = 0.002), MI (OR 0.72, 95 % CI 0.61-0.85, p = 0.0001) and revascularization (OR 0.76, 95 % CI 0.67-0.86, p < 0.0001), without any differences in CV death or stroke. Total adverse events, gastrointestinal and gallbladder-related disorders were higher in the GLP-1 RA group, with a similar rate of renal adverse events, malignant neoplasms and acute pancreatitis to placebo. CONCLUSION: In overweight or obese patients without DM, patients treated with GLP-1 RAs had significantly reduced MACE, all cause death, MI and revascularization when compared with placebo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesMyocardial InfarctionStrokeMaleHumansMiddle AgedFemaleHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsOverweightGlucagon-Like Peptide 1Obesity

Stichwörter der Autor:innen

Cardiovascular eventsGlucagon-like peptide-1 receptor agonistsOverweight or obesePatients without diabetes

Substanzen

Hypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide 1

Autor:innen und Institutionen

  • Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD, USA.
  • Division of Cardiology, Ellis Hospital, NY, USA.
  • Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, Baltimore, MD, USA.
  • Division of Cardiology, Sinai Hospital of Baltimore, Baltimore, MD, USA.
  • Division of Cardiology, Smidt Heart Institute, Los Angeles, CA, USA. Electronic address: martha.gulati@csmc.edu.

Zitieren

APA

Singh, S., Garg, A., Tantry, U. S., Bliden, K., Gurbel, P. A., & Gulati, M. (2024). Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients. Current Problems in Cardiology, 49(3), 102403. https://doi.org/10.1016/j.cpcardiol.2024.102403

Vancouver

Singh S, Garg A, Tantry US, Bliden K, Gurbel PA, Gulati M. Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients. Current Problems in Cardiology. 2024;49(3):102403. doi:10.1016/j.cpcardiol.2024.102403

BibTeX
@article{Singh2024,
  author = {Singh, Sahib and Garg, Aakash and Tantry, Udaya S and Bliden, Kevin and Gurbel, Paul A and Gulati, Martha},
  title = {Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients},
  journal = {Current Problems in Cardiology},
  year = {2024},
  volume = {49},
  number = {3},
  pages = {102403},
  doi = {10.1016/j.cpcardiol.2024.102403}
}
Kostenlos starten →